These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 35163300)

  • 1. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.
    Cheng CH; Chen LR; Chen KH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview.
    Wang LT; Chen LR; Chen KH
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
    Thouverey C; Caverzasio J
    Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
    Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
    Wang T; Yu X; He C
    Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.
    Blaschke M; Koepp R; Cortis J; Komrakova M; Schieker M; Hempel U; Siggelkow H
    Adv Clin Exp Med; 2018 Jan; 27(1):45-56. PubMed ID: 29521042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis.
    Chen Z; Jiang M; Mo L; Zhou C; Huang H; Ma C; Wang Z; Fan Y; Chen Z; Fang B; Liu Y
    Int Immunopharmacol; 2024 Nov; 141():112906. PubMed ID: 39173403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of glucocorticoid on bone-forming and bone-resorbing cells].
    Hakeda Y
    Clin Calcium; 2006 Nov; 16(11):1817-22. PubMed ID: 17079848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the antiosteoporotic mechanism of the soy-derived isoflavone genistein: Modulation of the Wnt/beta-catenin signaling.
    Mannino F; Imbesi C; Irrera N; Pallio G; Squadrito F; Bitto A
    Biofactors; 2024; 50(2):347-359. PubMed ID: 37767998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis.
    Sang C; Zhang J; Zhang Y; Chen F; Cao X; Guo L
    J Cell Physiol; 2017 Dec; 232(12):3396-3408. PubMed ID: 28059444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosapentaenoic acid supplementation modulates the osteoblast/osteoclast balance in inflammatory environments and protects against estrogen deficiency-induced bone loss in mice.
    Wang Z; Wu J; Li L; Wang K; Wu X; Chen H; Shi J; Zhou C; Zhang W; Hang K; Xue D; Pan Z
    Clin Nutr; 2023 Sep; 42(9):1715-1727. PubMed ID: 37542949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
    Fischer V; Haffner-Luntzer M
    Semin Cell Dev Biol; 2022 Mar; 123():14-21. PubMed ID: 34024716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss.
    Brunetti G; Storlino G; Oranger A; Colaianni G; Faienza MF; Ingravallo G; Di Comite M; Reseland JE; Celi M; Tarantino U; Passeri G; Ware CF; Grano M; Colucci S
    J Pathol; 2020 Apr; 250(4):440-451. PubMed ID: 31990039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular etiology and treatment of glucocorticoid-induced osteoporosis.
    Peng CH; Lin WY; Yeh KT; Chen IH; Wu WT; Lin MD
    Tzu Chi Med J; 2021; 33(3):212-223. PubMed ID: 34386357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.